138 related articles for article (PubMed ID: 12177690)
1. Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemia.
Grover GJ; Atwal KS
Cardiovasc Drug Rev; 2002; 20(2):121-36. PubMed ID: 12177690
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effects.
Grover GJ; D'Alonzo AJ; Darbenzio RB; Parham CS; Hess TA; Bathala MS
J Pharmacol Exp Ther; 2002 Oct; 303(1):132-40. PubMed ID: 12235243
[TBL] [Abstract][Full Text] [Related]
4. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
Grover GJ; Sleph PG; Dzwonczyk S; Malone HJ; Behling RW
J Cardiovasc Pharmacol; 1997 Jan; 29(1):28-38. PubMed ID: 9007667
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the protective effects of a highly selective ATP-sensitive potassium channel opener and ischemic preconditioning in isolated human atrial muscle.
Carr CS; Grover GJ; Pugsley WB; Yellon DM
Cardiovasc Drugs Ther; 1997 Jul; 11(3):473-8. PubMed ID: 9310276
[TBL] [Abstract][Full Text] [Related]
7. BMS-191095, a cardioselective mitochondrial K(ATP) opener, inhibits human platelet aggregation by opening mitochondrial K(ATP) channels.
Cho MR; Park JW; Jung IS; Yi KY; Yoo SE; Chung HJ; Yun YP; Kwon SH; Shin HS
Arch Pharm Res; 2005 Jan; 28(1):61-7. PubMed ID: 15742810
[TBL] [Abstract][Full Text] [Related]
8. Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning.
Ahmad N; Wang Y; Haider KH; Wang B; Pasha Z; Uzun O; Ashraf M
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2402-8. PubMed ID: 16687609
[TBL] [Abstract][Full Text] [Related]
9. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
[TBL] [Abstract][Full Text] [Related]
10. KR-31761, a novel K+(ATP)-channel opener, exerts cardioprotective effects by opening both mitochondrial K+(ATP) and Sarcolemmal K+(ATP) channels in rat models of ischemia/reperfusion-induced heart injury.
Yang MK; Lee SH; Seo HW; Yi KY; Yoo SE; Lee BH; Chung HJ; Won HS; Lee CS; Kwon SH; Choi WS; Shin HS
J Pharmacol Sci; 2009 Feb; 109(2):222-32. PubMed ID: 19234365
[TBL] [Abstract][Full Text] [Related]
11. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution.
Grover GJ; Sleph PG
J Cardiovasc Pharmacol; 1995 Nov; 26(5):698-706. PubMed ID: 8637183
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
Gross GJ; Mei DA; Sleph PG; Grover GJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):533-40. PubMed ID: 9023261
[TBL] [Abstract][Full Text] [Related]
14. Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
Ding CZ; Rovnyak GC; Misra RN; Grover GJ; Miller AV; Ahmed SZ; Kelly Y; Normandin DE; Sleph PG; Atwal KS
J Med Chem; 1999 Sep; 42(18):3711-7. PubMed ID: 10479302
[TBL] [Abstract][Full Text] [Related]
15. A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
D'Alonzo AJ; Darbenzio RB; Sewter JC; Hess TA; Grover GJ; Sleph PG; Normandin DE; Lodge NJ
Eur J Pharmacol; 1995 Dec; 294(1):271-80. PubMed ID: 8788441
[TBL] [Abstract][Full Text] [Related]
16. BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.
Grover GJ; Parham CS; Whigan DB; Mitroka JG
J Pharmacol Exp Ther; 1996 Feb; 276(2):380-7. PubMed ID: 8632300
[TBL] [Abstract][Full Text] [Related]
17. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice.
Suzuki M; Saito T; Sato T; Tamagawa M; Miki T; Seino S; Nakaya H
Circulation; 2003 Feb; 107(5):682-5. PubMed ID: 12578868
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of ischemia/reperfusion injury in isolated rats hearts by the ATP-sensitive potassium channel opener BMS-180448.
Monticello TM; Sargent CA; McGill JR; Barton DS; Grover GJ
Cardiovasc Res; 1996 Jan; 31(1):93-101. PubMed ID: 8849593
[TBL] [Abstract][Full Text] [Related]
20. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
